{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260807393777/en/AbCellera-to-Announce-Top-Line-Results-from-the-Phase-2-Trial-of-ABCL635-for-the-Treatment-of-Moderate-to-Severe-VMS-Due-to-Menopause-on-Monday-August-10-2026", "message": "News view counter 870791 successfully enlarged"}